Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Depreciation and Depletion (2019 - 2025)

ADC Therapeutics has reported Depreciation and Depletion over the past 7 years, most recently at $362000.0 for Q2 2025.

  • Quarterly results put Depreciation and Depletion at $362000.0 for Q2 2025, up 11.04% from a year ago — trailing twelve months through Dec 2025 was $704000.0 (down 47.23% YoY), and the annual figure for FY2025 was $705000.0, down 47.15%.
  • Depreciation and Depletion reached $362000.0 in Q2 2025 per ADCT's latest filing, up from $342000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $1.1 million in Q4 2022 and bottomed at $174.0 in Q1 2021.
  • Median Depreciation and Depletion over the past 5 years was $294500.0 (2023), compared with a mean of $238106.7.
  • The largest annual shift saw Depreciation and Depletion plummeted 99.88% in 2021 before it surged 312357.82% in 2022.
  • Over 5 years, Depreciation and Depletion stood at $339.0 in 2021, then soared by 312357.82% to $1.1 million in 2022, then plummeted by 68.37% to $335000.0 in 2023, then rose by 1.79% to $341000.0 in 2024, then increased by 6.16% to $362000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for ADCT at $362000.0 in Q2 2025, $342000.0 in Q1 2025, and $341000.0 in Q4 2024.